Cantitate/Preț
Produs

Law and Economics of Personalized Medicine: Institutional Levers to Foster the Translation of Personalized Medicine: Gesundheitsmanagement und Gesundheitsökonomik

Autor Karin Bosshard
en Limba Engleză Paperback – 24 mai 2018
The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice.
Citește tot Restrânge

Din seria Gesundheitsmanagement und Gesundheitsökonomik

Preț: 38507 lei

Nou

Puncte Express: 578

Preț estimativ în valută:
7370 7661$ 6105£

Carte tipărită la comandă

Livrare economică 04-18 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783658220730
ISBN-10: 3658220732
Pagini: 404
Ilustrații: XXXVI, 411 p. 41 illus., 7 illus. in color.
Dimensiuni: 148 x 210 mm
Greutate: 0.53 kg
Ediția:1st ed. 2018
Editura: Springer Fachmedien Wiesbaden
Colecția Springer Gabler
Seria Gesundheitsmanagement und Gesundheitsökonomik

Locul publicării:Wiesbaden, Germany

Cuprins

Overview of terminologies used in the context of personalized medicine.- Description of personalized medicine’s impact on the healthcare landscape.- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice.- Analysis of institutional barriers to the translation of personalized medicine in Switzerland.- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.

Notă biografică

Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.

Textul de pe ultima copertă

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice.

The content
•Overview of terminologies used in the context of personalized medicine
•Description of personalized medicine’s impact on the healthcare landscape
•Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice
•Analysis of institutional barriers to the translation of personalized medicine in Switzerland
•Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice

Target groups
•Social scientists with limited knowledge of personalized medicine, Law and Economics scholars, health economists
•Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers

The author
Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.

Caracteristici

Comprehensive overview of the institutional barriers behind the translation of personalized medicine into clinical practice